paclitaxel has been researched along with Chronic Illness in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.65) | 18.2507 |
| 2000's | 18 (41.86) | 29.6817 |
| 2010's | 17 (39.53) | 24.3611 |
| 2020's | 6 (13.95) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Gao, F; Liu, N; Sang, Y; Wang, P; Wang, Q; Wu, Q; Zhang, X | 1 |
| Adams, KN; Ahmed, SJ; Akaputra, R; Akosman, I; Akya, A; Ali, S; Aminuddin, A; An, B; An, X; Anana, EV; Ao, L; Arany, Z; Arena, R; Azhar, A; Azhar, W; Baasankhuu, A; Bae, WK; Bahar, B; Balaji, L; Barbosa, M; Batchu, UR; Berg, KM; Berlin, N; Berthier, E; Bettiol, AA; Bi, B; Bodie, D; Borges, VF; Borghi-Silva, A; Bowman, CE; Brantly, M; Budhathoki, L; Bukhari, A; Cabeza, M; Cao, J; Cao, Q; Cao, S; Carrasco-Nuñes, N; Caruso, FR; Carvalho, C; Chakrabarty, D; Chandra Mondal, P; Chandran, V; Chang, P; Chase, M; Chauhan, AS; Chauhan, PS; Che, J; Cheemalamarri, C; Chen, D; Chen, H; Chen, J; Chen, Q; Chen, X; Chen, Z; Chetri, BK; Cho, SW; Choi, TI; Chung, HC; Cocchi, MN; Collins, LC; Colombo, N; Come, SE; Custodio, JM; Dai, TY; De La Garza Ramos, R; de Oliveira, CR; Dębczak, A; DeMuri, GP; Deng, J; Deng, K; Dhanani, LY; Diaz, S; Djaharuddin, I; Dong, G; Dong, Q; Donnino, MW; Dwiyanti, R; Elango, KP; Eleswarapu, A; Evans, EGB; Fachri, M; Fang, Y; Fantappiè, G; Farasat, A; Farsida, F; Fathimah, A; Febrianti, A; Feng, S; Fernandes, V; Fernandez Garcia, E; Fleming, GF; Foskett, JK; Fourman, MS; Fu, M; Fu, W; Fukushima, S; Gahlay, GK; Gai, S; Gao, R; Gao, W; Gilbert, DM; Gong, J; Gong, MN; Gong, Z; González-Cavieres, L; Gordon, SE; Goudarzi, F; Goulart, CDL; Greenstein, AE; Grigg, ARC; Grilli, D; Grisham, RN; Grossestreuer, AV; Grzęda, A; Grzegorczyk, A; Gu, J; Guo, H; Gupta, R; Haldar, A; Hamid, Y; Han, HJ; Hancock, CN; Hassan, GW; Hatta, M; He, D; He, F; He, J; Heidarinia, H; Helmchen, G; Herrera-Lavados, C; Hieber, DL; Hoehr, C; Hou, L; Huang, C; Huang, J; Hussain, S; Imaoka, S; Indoliya, Y; Jain, E; Jana, S; Jang, H; Jang, HS; Jara-Quijada, E; Jeacopello, I; Jeung, HC; Jiang, B; Jiang, D; Jiang, G; Jiang, L; Jiang, Q; Jiang, Y; Jiang, Z; Jiao, Z; Jr, JCB; Jung, M; Jung, S; Junita, AR; Kalavathi, A; Kang, X; Kannan, R; Kato, K; Khadka, M; Khan, AR; Khan, I; Khodayari, N; Kim, BJ; Kim, CG; Kim, CH; Kim, D; Kim, H; Kim, HS; Kim, HT; Kim, TS; Kim, YT; King, R; Koh, K; Konkol, M; Koo, DH; Kretzschmar, R; Krop, IE; Kuang, Y; Kubeneck, LJ; Kulkarni, K; Kumar, N; Kunjan, C; Kwon, WS; Lai, C; Lans, A; Lascano, J; Lavania, UC; Lee, CK; Lee, DA; Lee, HS; Lee, J; Lee, KH; Lee, MS; Lee, SW; Lee, UN; Lemus-Mondaca, R; Li, HR; Li, J; Li, Q; Li, X; Li, Y; Li, Z; Liang, H; Liang, Y; Lin, L; Lin, Y; Lipsyc-Sharf, M; Liu, B; Liu, C; Liu, DX; Liu, H; Liu, J; Liu, K; Liu, S; Liu, X; Liu, Z; Locknane, MP; Lorusso, D; Lü, H; Luo, Z; Lv, X; Ma, Y; Mandava, K; Manfrinetti, P; Mao, W; Marques-Sá, J; Masaki, T; Massi, MN; Matsuse, M; Matulonis, UA; Maxwell, CA; McAssey, EV; McManamen, AM; Mehl, RA; Mendes, RG; Meng, Z; Miao, Z; Miller, S; Milovanovic, S; Mishra, SK; Mitra, S; Mitsutake, N; Miyazaki, Y; Moriwaki, S; Mortenson, R; Moskowitz, A; Mudring, AV; Mues Genannt Koers, L; Muhammad, S; Muhimpundu, S; Murapaka, C; Murota, H; Mv, S; Nakazawa, Y; Nam, CM; Natzir, R; Ngo, L; Nguyen, DD; Nie, Y; Nishigori, C; Noji, MC; Notini, L; Oaknin, A; Ogi, T; Oguro, A; Okukawa, K; Olawaiye, AB; Omble, AD; Oso, T; Page, CA; Palma-Acevedo, A; Pani, M; Parikh, SM; Park, J; Park, S; Partridge, AH; Pashova, HI; Paudel, U; Paulssen, E; Payero, L; Peng, M; Peppercorn, JM; Pérez-Won, M; Pitarresi, JR; Pradhan, J; Prevost, D; Primaguna, MR; Puvvada, N; Qian, D; Rajaure, YS; Rajca, A; Rajput, N; Rana, SR; Rangan, L; Ranjbarian, P; Redd, PS; Ren, T; Rha, SY; Riley, L; Romano, M; Rong, X; Rosenberg, SM; Rostamian, M; Rothwell, KA; Ru, S; Ruddy, KJ; Rustgi, AK; Salam, A; Sankaran, S; Santoso, A; Saravanakumar, P; Satheeshkumar, K; Schapira, L; Schulz, K; Senapati, A; Senju, C; Sharma, P; Shelke, RG; Shen, F; Shen, X; Shen, Y; Sheteiwy, MS; Shetty, PR; Shi, L; Shi, MM; Shiigi, H; Shimada, M; Shinkawa, VAM; Shtender, V; Siswanto, FM; Smetana, V; Snow, C; Sridiana, E; Stephenson, MW; Stoll, S; Su, X; Sun, S; Sun, XF; Surapaneni, JR; Suri, K; Świątek, Ł; Syukri, A; Tabilo-Munizaga, G; Takezawa, MG; Tamimi, RM; Tamura, A; Tanaka, K; Tang, M; Tao, Y; Tateishi, S; Thapa, B; Theberge, AB; ThomasArrigo, LK; Thongpang, S; Tiwari, M; Tong, Q; Totton, RR; Tripathi, RD; Tsujimoto, M; Tu, WC; Tudor, IC; Tyskiewicz, K; Ubaidah, FM; Ulhassan, Z; Utani, A; Van Gorp, T; Veerapandian, V; Vennila, KN; von Gunten, U; Wagle, N; Waks, AG; Wald, ER; Wang, B; Wang, D; Wang, H; Wang, L; Wang, W; Wang, X; Wang, Y; Wang, Z; Warner, E; Waterhouse, GIN; Weiss, J; Weissenrieder, JS; Wellen, KE; Wu, JY; Xiang, W; Xiao, S; Xie, Q; Xu, F; Xu, TW; Xu, Y; Yan, B; Yan, JM; Yang, D; Yang, P; Yang, S; Yang, W; Yao, Y; Yassari, R; Yong, Q; Yu, H; Yu, Z; Yun, UJ; Zagotta, WN; Zang, DY; Zanudo, JGT; Zeng, A; Zhang, H; Zhang, R; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YT; Zhao, C; Zhao, J; Zhong, S; Zhou, F; Zhou, W; Zhou, Y | 1 |
| Dandona, S; Daneault, B; Rinfret, S; Ybarra, LF | 1 |
| Dinh, K; Gomes, ML; Holden, A; Paravastu, SCV; Schneider, PA; Thomas, SD; Varcoe, RL | 1 |
| Behrendt, CA; Debus, ES; Heidemann, F; Kreutzburg, T; Kuchenbecker, J; L'Hoest, H; Marschall, U; Peters, F; Sedrakyan, A | 1 |
| Ambani, RN; Bose, S; Cho, JS; Colvard, B; Harth, KC; Kashyap, VS; King, AH; Kumins, NH; Thomas, JP; Wong, VL | 1 |
| Fukai, K; Kamo, R; Nishida, M; Tsuruta, D | 1 |
| Dabouz, F; Farhat, MM; Le Guern, A; Modiano, P; Peugniez, C; Quinchon, JF | 1 |
| Argyriou, A; Beropoulis, E; Bisdas, T; Stavroulakis, K; Torsello, G | 1 |
| Jaff, MR; Keirse, K; Li, P; Micari, A; Scheinert, D; Schmahl, R; Tepe, G; Zeller, T | 1 |
| Basavarajaiah, S; Bernelli, C; Carlino, M; Chieffo, A; Colombo, A; Ferrarello, S; Figini, F; Fujino, Y; Godino, C; Hasegawa, T; Ielasi, A; Latib, A; Mizuno, H; Montorfano, M; Naganuma, T; Nakamura, S; Rezq, A; Shannon, J; Takagi, K | 1 |
| Castro Junior, CJ; Cordeiro, Mdo N; Dalmolin, GD; Ferreira, J; Gomez, MV; Klafke, JZ; Montijo, D; Rigo, FK; Rossato, MF; Silva, MA; Tonello, R; Trevisan, G | 1 |
| Chae, IH; Gwon, HC; Hur, SH; Jang, Y; Kang, SH; Kim, HS; Kim, MH; Lee, JM; Lee, MH; Lee, SH; Park, HS; Rha, SW; Yoon, CH; Yu, CW | 1 |
| Diaz-Cartelle, J; Keirse, K; Müller-Hülsbeck, S; Schroë, H; Zeller, T | 1 |
| Briguori, C; Taranto, D; Visconti, G | 1 |
| Güth, U; Holzgreve, W; Huang, DJ; Kann, SR; Schötzau, A; Wight, E | 1 |
| Changqi, J; Changsheng, M; Chengxiong, G; Fang, C; Fangjiong, H; Jiahui, W; Jianzeng, D; Junping, K; Qiang, L; Rong, H; Shaoping, N; Shuzheng, L; Xiaohui, L; Xin, D; Xinmin, L; Xuesi, W; Yan, Q; Yin, Z; Yujie, Z | 1 |
| Chae, IH; Cho, YS; Choi, DJ; Kang, HJ; Kim, HS; Kim, SY; Koo, BK; Lee, SP; Park, KW; Shin, DH; Suh, JW; Yeon, TJ | 1 |
| Chow, WH; Ho, HH; Jim, MH; Ko, RL; Lau, CP; Siu, CW; Yiu, KH | 1 |
| Agostoni, P; Banerjee, S; Brilakis, ES; Kandzari, DE; Lombardi, WL; Rangan, BV; Saeed, B | 1 |
| Suzuki, M; Takagi, Y; Tsuchikane, E | 1 |
| Grigsby, PW; Schwarz, JK; Wahab, S | 1 |
| Bowman, TS; Cox, DA; Dawkins, KD; Huang, PH; Lasala, JM; Starzyk, RM; Yeung, M | 1 |
| Antoniucci, D; Buonamici, P; Carrabba, N; Cerisano, G; Migliorini, A; Parodi, G; Valenti, R; Vergara, R | 1 |
| Werner, GS; Wöhrle, J | 1 |
| Beckhove, P; Kato, M; Michels, T; Sevko, A; Shurin, GV; Shurin, MR; Umansky, L; Umansky, V; Vrohlings, M | 1 |
| Altmeyer, P; Ardabili, M; Gambichler, T; Hoffmann, K; Rotterdam, S; Stücker, M | 1 |
| Elson, DL; Natarajan, M; Saravanan, SM | 1 |
| Akedo, I; Kubo, M; Mori, M; Nakagawa, C; Nishida, Y; Ono, H; Sakai, K; Takeda, E; Tamura, K; Tsugawa, M; Yanagi, K | 1 |
| Betge, S; Figulla, HR; Krack, A; Prochnau, D; Schwarz, G; Werner, GS | 1 |
| Buellesfeld, L; Gerckens, U; Grube, E; Mueller, R; Schmidt, T | 1 |
| Belinson, JL; Michener, CM | 1 |
| Betge, S; Figulla, HR; Fritzenwanger, M; Krack, A; Prochnau, D; Schwarz, G; Werner, GS | 1 |
| Antoniucci, D; Carrabba, N; Migliorini, A; Moschi, G; Parodi, G; Vergara, R | 1 |
| Han, KH; Hong, MK; Jang, JS; Kim, JJ; Kim, YH; Lee, BK; Lee, CW; Park, DW; Park, SJ; Park, SW | 1 |
| Anderson, HV; Hemstreet, P | 1 |
| Alfonso, F; Angiolillo, DJ; Bass, TA; Cervinka, P; Corros, C; Costa, MA; Futamatsu, H; Hernandez-Antolin, R; Jiang, J; Jimenez-Quevedo, P; Macaya, C; Morikawa-Futamatsu, K; Sabaté, M | 1 |
| De Felice, F; Fiorilli, R; Violini, R | 1 |
| Chlorogiannis, I; Iliopoulos, D; Panagiotou, M; Patsa, C; Pattakos, E; Spanos, A; Stefanadi, E; Stefanadis, C; Toutouzas, K; Tsiamis, E; Vaina, S; Vavuranakis, M | 1 |
| De Felice, F; Dibra, A; Fiorilli, R; Menichelli, M; Musto, C; Nazzaro, MS; Parma, A; Pucci, E; Violini, R | 1 |
| Krylov, AL; Maslov, LN | 1 |
| Basu, A; Croce, CM; Haldar, S | 1 |
| Bachier, C; Cabanillas, F; Hagemeister, F; McLaughlin, P; Mesina, O; Preti, HA; Rodriguez, MA; Romaguera, J; Sarris, AH; Younes, A | 1 |
5 review(s) available for paclitaxel and Chronic Illness
| Article | Year |
|---|---|
Mortality After Paclitaxel-Coated Device Use in Patients With Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Topics: Aged; Angioplasty, Balloon; Cardiovascular Agents; Cause of Death; Chronic Disease; Coated Materials, Biocompatible; Drug-Eluting Stents; Female; Humans; Ischemia; Male; Paclitaxel; Peripheral Arterial Disease; Prosthesis Design; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Vascular Access Devices | 2020 |
Use of drug-eluting stents for chronic total occlusions: a systematic review and meta-analysis.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Chronic Disease; Coronary Angiography; Coronary Occlusion; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Patient Selection; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome | 2011 |
Advanced ovarian carcinoma as a chronic disease: a case report and review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cisplatin; Cystadenocarcinoma; Female; Humans; Ifosfamide; Laparotomy; Ovarian Neoplasms; Paclitaxel; Survival Rate; Taxoids; Ultrasonography; Vagina | 2003 |
[Chronic total coronary occlusions: an overview].
Topics: Angioplasty, Balloon, Coronary; Angioplasty, Laser; Chronic Disease; Coronary Disease; Coronary Restenosis; Humans; Myocardial Revascularization; Paclitaxel; Stents; Treatment Outcome; Tubulin Modulators | 2006 |
[Paclitaxel-eluting stents in treatment of stenoses and chronic occlusions of coronary arteries].
Topics: Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Chronic Disease; Coated Materials, Biocompatible; Coronary Stenosis; Humans; Paclitaxel; Stents; Treatment Outcome | 2007 |
9 trial(s) available for paclitaxel and Chronic Illness
| Article | Year |
|---|---|
Camrelizumab (SHR-1210) with carboplatin and albumin-binding paclitaxel in patients with metastatic or recurrent cervical cancer: An open-label, phase 2 trial.
Topics: Albumin-Bound Paclitaxel; Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chronic Disease; Female; Humans; Paclitaxel; Prospective Studies; Uterine Cervical Neoplasms | 2022 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Acute Kidney Injury; Adult; Aged; Albumins; Alloys; Amides; Amino Acids; Animals; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Bioaccumulation; Blood Glucose; Brain; Brassica napus; Breast Neoplasms; Carcinoma, Ovarian Epithelial; Catalysis; Child; China; Chlorides; Chlorine; Chromium; Chronic Disease; Cohort Studies; Copper; Corrosion; COVID-19; Creatinine; Dermatitis; Diabetes Mellitus; Diazepam; Disease-Free Survival; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Dyspnea; Electron Spin Resonance Spectroscopy; Environmental Monitoring; Escherichia coli; Escherichia coli Infections; Esophageal Neoplasms; Esophagogastric Junction; Estradiol; Exercise Test; Exercise Tolerance; Female; Ferric Compounds; Fishes; Food Chain; gamma-Aminobutyric Acid; Genomics; Halogenation; HEK293 Cells; Hemolysis; Heterocyclic Compounds; Hospitalization; Humans; Hydrogen Peroxide; Hyperglycemia; Introns; Iron; Kidney; Kinetics; Laboratories; Limit of Detection; Lipopolysaccharides; Liver Neoplasms; Magnesium; Male; Mammals; Materials Testing; Mercury; Metal-Organic Frameworks; Methylmercury Compounds; Mice; Microscopy, Electron, Scanning; Mifepristone; Minerals; Molecular Weight; Mutation; Nanoparticles; Neuroprotection; NF-kappa B; Nitrates; Nitrogen; NLR Family, Pyrin Domain-Containing 3 Protein; Orthopedics; Ovarian Neoplasms; Ovariectomy; Oxidation-Reduction; Oxidative Stress; Oxygen; Oxygen Consumption; Paclitaxel; Phenols; Progesterone; Prospective Studies; Proteins; Protons; Pulmonary Disease, Chronic Obstructive; Ramucirumab; Rats; Receptor, ErbB-2; Respiratory Function Tests; Retrospective Studies; Saliva; SARS-CoV-2; Seeds; Sesbania; Shock, Septic; Silicon Dioxide; Sleep; Soil; Specimen Handling; Spectroscopy, Mossbauer; Spin Labels; Staphylococcus aureus; Stomach Neoplasms; Streptococcus mutans; Thiamine; Toll-Like Receptor 2; Toll-Like Receptor 4; Trastuzumab; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases; Water; Water Pollutants, Chemical; Water Purification; Xeroderma Pigmentosum; Zebrafish | 2023 |
Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The Chronic Total Occlusion Cohort in the IN.PACT Global Study.
Topics: Aged; Amputation, Surgical; Angioplasty, Balloon; Cardiovascular Agents; Chronic Disease; Coated Materials, Biocompatible; Constriction, Pathologic; Equipment Design; Female; Femoral Artery; Humans; Limb Salvage; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Progression-Free Survival; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Time Factors; Vascular Access Devices; Vascular Patency | 2019 |
Comparison of outcomes after percutaneous coronary intervention for chronic total occlusion using everolimus- versus sirolimus- versus paclitaxel-eluting stents (from the Korean National Registry of Chronic Total Occlusion Intervention).
Topics: Antineoplastic Agents; Chronic Disease; Coronary Angiography; Coronary Occlusion; Drug-Eluting Stents; Electrocardiography; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Registries; Republic of Korea; Retrospective Studies; Sirolimus; Survival Rate; Treatment Outcome | 2015 |
Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease.
Topics: Aged; Alloys; Ankle Brachial Index; Australia; Blood Flow Velocity; Cardiovascular Agents; Chronic Disease; Constriction, Pathologic; Drug-Eluting Stents; Endovascular Procedures; Europe; Female; Femoral Artery; Humans; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Male; Middle Aged; New Zealand; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Prospective Studies; Prosthesis Design; Regional Blood Flow; Self Expandable Metallic Stents; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vascular Patency | 2016 |
Prospective phase I-II trial of helical tomotherapy with or without chemotherapy for postoperative cervical cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemoradiotherapy; Chronic Disease; Cisplatin; Diarrhea; Disease-Free Survival; Feasibility Studies; Female; Follow-Up Studies; Humans; Lymph Nodes; Middle Aged; Nausea; Neoplasm Invasiveness; Organs at Risk; Paclitaxel; Prospective Studies; Radiotherapy, Intensity-Modulated; Tumor Burden; Uterine Cervical Neoplasms; Vesicovaginal Fistula | 2011 |
Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Chi-Square Distribution; Chronic Disease; Coated Materials, Biocompatible; Coronary Angiography; Coronary Occlusion; Coronary Restenosis; Drug Therapy, Combination; Drug-Eluting Stents; Equipment Design; Female; Germany; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Stents; Time Factors; Treatment Outcome | 2013 |
Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Chronic Disease; Cohort Studies; Coronary Angiography; Coronary Disease; Coronary Restenosis; Diabetic Angiopathies; Female; Humans; Incidence; Male; Middle Aged; Paclitaxel; Secondary Prevention; Stents; Survival Analysis; Treatment Outcome | 2004 |
Paclitaxel plus high-dose cyclophosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cyclophosphamide; Disease-Free Survival; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Intradermal; Lymphoma, Non-Hodgkin; Male; Middle Aged; Paclitaxel; Recurrence; Treatment Outcome | 1998 |
29 other study(ies) available for paclitaxel and Chronic Illness
| Article | Year |
|---|---|
Drug-coated balloon after subintimal plaque modification in failed coronary chronic total occlusion percutaneous coronary intervention: A novel concept.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Chronic Disease; Coated Materials, Biocompatible; Coronary Occlusion; Female; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Stents; Treatment Failure | 2020 |
Long Term Outcomes After Revascularisations Below the Knee with Paclitaxel Coated Devices: A Propensity Score Matched Cohort Analysis.
Topics: Administrative Claims, Healthcare; Aged; Aged, 80 and over; Amputation, Surgical; Cardiovascular Agents; Chronic Disease; Coated Materials, Biocompatible; Databases, Factual; Drug-Eluting Stents; Endovascular Procedures; Female; Germany; Humans; Ischemia; Leg; Limb Salvage; Male; Paclitaxel; Peripheral Arterial Disease; Propensity Score; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2020 |
Paclitaxel-coated peripheral arterial devices are associated with improved overall survival and limb salvage in patients with chronic limb-threatening ischemia.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Angioplasty, Balloon; Cardiovascular Agents; Chronic Disease; Coated Materials, Biocompatible; Equipment Design; Female; Humans; Ischemia; Limb Salvage; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Progression-Free Survival; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors | 2021 |
Case of chronic venous insufficiency-associated Kaposi's sarcoma in a Japanese patient.
Topics: Aged; Antineoplastic Agents, Phytogenic; Biopsy; Chronic Disease; Diagnosis, Differential; Humans; Immunohistochemistry; Japan; Lower Extremity; Male; Paclitaxel; Sarcoma, Kaposi; Venous Insufficiency | 2017 |
[Angiosarcoma in primary lymphoedema: A rare complication].
Topics: Aged; Antineoplastic Agents, Phytogenic; Chronic Disease; Fatal Outcome; Female; Hemangiosarcoma; Humans; Lower Extremity; Lymphedema; Paclitaxel; Skin Neoplasms | 2018 |
1-Year All-Comers Analysis of the Eluvia Drug-Eluting Stent for Long Femoropopliteal Lesions After Suboptimal Angioplasty.
Topics: Aged; Angioplasty; Cardiovascular Agents; Chronic Disease; Constriction, Pathologic; Drug-Eluting Stents; Female; Femoral Artery; Humans; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Prosthesis Design; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome; Vascular Calcification; Vascular Patency | 2018 |
Impact of residual chronic total occlusion of right coronary artery on the long-term outcome in patients treated for unprotected left main disease: the Milan and New-Tokyo registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Chronic Disease; Coronary Circulation; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Death, Sudden, Cardiac; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Registries; Retrospective Studies; Tubulin Modulators | 2013 |
Effect of ω-conotoxin MVIIA and Phα1β on paclitaxel-induced acute and chronic pain.
Topics: Acute Disease; Analgesics; Animals; Behavior, Animal; Chronic Disease; Male; omega-Conotoxins; Paclitaxel; Pain; Rats; Rats, Wistar; Spider Venoms | 2013 |
Recalcitrant in-stent restenosis of the celiac trunk treated by drug-eluting stent.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Cardiovascular Agents; Celiac Artery; Chronic Disease; Constriction, Pathologic; Drug-Eluting Stents; Female; Humans; Ischemia; Magnetic Resonance Angiography; Mesenteric Vascular Occlusion; Metals; Paclitaxel; Prosthesis Design; Recurrence; Stents; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Systemic therapy developments and their effects regarding the current concept of recurrent ovarian carcinoma as a chronic disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chronic Disease; Cohort Studies; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel | 2009 |
Percutaneous treatment with drug-eluting stent vs bypass surgery in patients suffering from chronic stable angina with multivessel disease involving significant proximal stenosis in left anterior descending artery.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cerebrovascular Disorders; Chronic Disease; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Drug-Eluting Stents; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Registries; Reoperation; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2009 |
Long-term clinical outcome of chronic total occlusive lesions treated with drug-eluting stents: comparison of sirolimus-eluting and paclitaxel-eluting stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Chronic Disease; Cohort Studies; Coronary Angiography; Coronary Occlusion; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Recurrence; Registries; Sirolimus; Treatment Failure; Treatment Outcome | 2010 |
Paclitaxel-eluting stents for chronically occluded saphenous vein grafts (EOS) study.
Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Chronic Disease; Coronary Angiography; Coronary Artery Bypass; Coronary Restenosis; Drug-Eluting Stents; Feasibility Studies; Female; Graft Occlusion, Vascular; Hong Kong; Hospital Mortality; Humans; Male; Paclitaxel; Registries; Saphenous Vein; Time Factors; Treatment Outcome | 2010 |
Percutaneous coronary intervention of chronic total occlusion in a left anterior descending coronary artery using an ipsilateral intraseptal bridging collateral tracking technique.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chronic Disease; Collateral Circulation; Coronary Angiography; Coronary Circulation; Coronary Occlusion; Drug-Eluting Stents; Humans; Male; Paclitaxel; Treatment Outcome | 2010 |
Two-year clinical outcomes with paclitaxel-eluting coronary stents in patients with chronic total occlusions: analysis from the TAXUS ARRIVE program.
Topics: Aged; Angioplasty, Balloon, Coronary; Chronic Disease; Cohort Studies; Coronary Occlusion; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Postoperative Complications; Prospective Studies; Registries; Time Factors; Treatment Outcome | 2011 |
Comparison of everolimus-eluting stent with paclitaxel-eluting stent in long chronic total occlusions.
Topics: Aged; Chronic Disease; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Disease-Free Survival; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Paclitaxel; Sirolimus; Treatment Outcome | 2011 |
Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Calgranulin B; Chronic Disease; Dose-Response Relationship, Immunologic; Humans; Immunosuppression Therapy; Inflammation; Melanoma; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitogen-Activated Protein Kinases; Myeloid Cells; Paclitaxel; Primary Cell Culture; Skin Neoplasms; Spleen; Tumor Microenvironment; Tumor Necrosis Factor-alpha | 2013 |
Metastatic cutaneous squamous cell carcinoma arising from a previous area of chronic hypertrophic lichen planus.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Chronic Disease; Cisplatin; Groin; Humans; Leg; Lichen Planus; Lymphatic Metastasis; Male; Paclitaxel; Skin Neoplasms | 2003 |
[A case of non-small cell lung carcinoma successfully treated with carboplatin and weekly paclitaxel under renal dysfunction].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chronic Disease; Drug Administration Schedule; Humans; Lung Neoplasms; Male; Nephritis; Paclitaxel; Pleural Effusion, Malignant; Renal Insufficiency | 2004 |
Polymer-based paclitaxel-eluting stent for treatment of chronic total occlusions of native coronaries: results of a Taxus CTO registry.
Topics: Antineoplastic Agents, Phytogenic; Chronic Disease; Coronary Angiography; Coronary Stenosis; Delayed-Action Preparations; Drug Implants; Female; Humans; Male; Middle Aged; Paclitaxel; Polymers; Prospective Studies; Registries; Stents; Treatment Outcome | 2005 |
Modern management of recurrent ovarian carcinoma. A systematic approach to a chronic disease.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chronic Disease; Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Salvage Therapy; Secondary Prevention; Topotecan | 2005 |
Paclitaxel-eluting stents for the treatment of chronic total coronary occlusions: a strategy of extensive lesion coverage with drug-eluting stents.
Topics: Aged; Antineoplastic Agents, Phytogenic; Chronic Disease; Constriction, Pathologic; Coronary Angiography; Coronary Disease; Coronary Vessels; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Design; Retrospective Studies; Stents | 2006 |
Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
Topics: Aged; Angioplasty, Balloon, Coronary; Case-Control Studies; Chi-Square Distribution; Chronic Disease; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug Delivery Systems; Female; Humans; Logistic Models; Male; Middle Aged; Paclitaxel; Proportional Hazards Models; Sirolimus; Stents; Treatment Outcome | 2006 |
Comparison between sirolimus- and Paclitaxel-eluting stents for the treatment of chronic total occlusions.
Topics: Adult; Chronic Disease; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Follow-Up Studies; Heart Diseases; Humans; Inpatients; Male; Middle Aged; Paclitaxel; Retrospective Studies; Sirolimus; Stents; Survival Analysis; Treatment Outcome | 2006 |
Sirolimus or paclitaxel drug-eluting stents for treatment of chronic total occlusions of coronary arteries: much ado about very little.
Topics: Chronic Disease; Coronary Disease; Humans; Paclitaxel; Sirolimus; Stents | 2006 |
Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study.
Topics: Aged; Chronic Disease; Coronary Disease; Coronary Stenosis; Diabetic Angiopathies; Drug Delivery Systems; Equipment Design; Female; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Male; Metals; Middle Aged; Multicenter Studies as Topic; Paclitaxel; Prolapse; Randomized Controlled Trials as Topic; Risk Assessment; Sirolimus; Stents; Treatment Outcome; Ultrasonography, Interventional | 2006 |
Drug eluting stents versus coronary artery bypass surgery in patients with isolated proximal lesion in left anterior descending artery suffering from chronic stable angina.
Topics: Angina Pectoris; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Chronic Disease; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Bypass; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Sirolimus; Stents; Time Factors; Treatment Outcome | 2007 |
Clinical outcome of patients with chronic total occlusion treated with drug-eluting stents.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Chronic Disease; Coronary Angiography; Coronary Occlusion; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Ischemia; Paclitaxel; Prognosis; Proportional Hazards Models; Retrospective Studies; Sirolimus; Stents; Treatment Outcome | 2009 |
Bcl2 is the guardian of microtubule integrity.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Chronic Disease; Docetaxel; G2 Phase; Humans; Leukemia; Lymphoma, B-Cell; Male; Microtubules; Paclitaxel; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Taxoids; Tumor Cells, Cultured | 1997 |